AzTrials
AzTrials

Occupational StressWRSNCT04948255

Measuring Work-Related Stress in Primary Care in the Covid-19 Pandemic

An observational study of Occupational Stress and Covid19, run by Dr. Faizan Awan at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective cohort study was designed to assess WRS amongst clinical and non-clinical staff in a primary healthcare setting using a validated tool with a view to developing an evidence base to form a historical and comparative record during the Covid-19 pandemic. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Occupational Stress, Covid19
What is being tested?
Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) to measure work-related stress
How many people
18 participants
Where
1 siteUnited Kingdom
Study dates
1 Apr 2019to 29 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Adult health professionals and administration staff

Who may be able to join

  • Primary healthcare staff working at the Gill Medical Centre for at least two months prior to assessment.

Who cannot join

  • Any staff member employed for less than two months, those who were off work due to non- stress related long-term leave or incomplete submissions.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The Gill Medical Centre

    Salford, Greater Manchester, M28 3DR

Other trials in United Kingdom

About this study

Official title: Work-Related Stress Amongst a Primary Care Workforce in Greater Manchester, United Kingdom Before and During the Covid-19 Pandemic

This prospective cohort study was designed to assess WRS amongst clinical and non-clinical staff in a primary healthcare setting using a validated tool with a view to developing an evidence base to form a historical and comparative record during the Covid-19 pandemic.

Read the detailed description

Work-related stress (WRS) is the second most common cause of occupational ill health in the United Kingdom. Studies suggest that during the Covid-19 pandemic, an increased prevalence of stress-related disorders was reported amongst healthcare workers. WRS can be assessed using the Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) and is used to compare changes to WRS across six domains over time. Lower scores in domains indicate higher WRS experienced by workers. Increases in the score in subsequent assessments indicate improvements to WRS. The MSIT was distributed to 23 primary care clinical and non-clinical staff in a medical centre in Greater Manchester, United Kingdom in March, 2019. 18 responses were received from 23 staff (78% response rate), establishing a baseline. In May, 2020, the authors decided to reanalyse the effect of the Covid-19 pandemic on WRS upon the same population. The MSIT was redistributed in March 2021, with 14 responses from 20 staff (70% response rate). Microsoft Excel's data analysis was applied to the results. WRS across the practice increased by 7% in demands, 4% in control and 2% in role domains and improved by 3% in support, 3% in relationships and 2% in change domains. The results are in keeping with the global picture of evolving WRS amongst healthcare staff during the pandemic. Monitoring and addressing WRS regularly helps maintain system-wide resilience when faced with unexpected or unprecedented change. Comparing these results with WRS in other healthcare systems would be a useful next step.

Being tested
Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) to measure work-related stress
Keywords
Pandemics, Primary health care
Medical subject headings
Occupational Stress, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) to measure work-related stressOther

    Questionnaire

Study groups in NCT04948255
Study groupRoleWhat they receive
Healthcare Workers at the Gill Medical CentreClinical and non-clinical staff at the Gill Medical Centre will complete a validated stress questionnaire during the Covid-19 pandemic. A baseline was established in May, 2019.
Receives: Other: Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) to measure work-related stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of stress across the workforce

    Work-related stress (WRS) is measured using the Management Standards Indicator Tool (MSIT) on a Likert scale of 1-5 with a higher number indicating less WRS. A measurement is made at baseline and during the Covid-19 pandemic.

    Measured: 24 months

Secondary outcomes (1)
  1. Measurement of stress by type of role

    WRS measured using MSIT across three different primary healthcare roles - doctors, other clinicians and administrators - at baseline from 2019 and during the Covid-19 pandemic

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2021
  2. Study start1 Apr 2019
  3. Primary completion29 Mar 2021
  4. Study completion29 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04948255
Sponsor's protocol ID
302893
Acronym
WRS
Status last verified
Jun 2021
First submitted
29 Jun 2021
Last updated
1 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Sharing of collected data with researchers using the same tool to assess work-related stress.

Questions about this trial

What is this clinical trial studying?

An observational study of Occupational Stress and Covid19, run by Dr. Faizan Awan at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of stress across the workforce (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in